In addition, SCFAs exert anti-inflammatory effects and help maintain intestinal barrier integrity, mechanisms that have been linked to a reduced risk of metabolic syndrome and improved insulin sensitivity [40,41]. The gene discussed is INS; the disease is metabolic syndrome.